AI assistant
BIO-TECHNE Corp — Director's Dealing 2019
Jun 14, 2019
30718_dirs_2019-06-14_ce38dff2-cd06-4a14-b725-5e33cdeb5f38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-06-12
Reporting Person: Eansor Norman David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-12 | Common Stock | S | 3117.00 | $215.00 | Disposed | 0.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (2287.00) | 2287.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (2174.00) | 2174.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (2537.00) | 2537.00 | Direct | |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (12500.00) | 12500.00 | Direct |
| Stock Option (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (15000.00) | 15000.00 | Direct |
| Stock Options (Right to buy) | $177.32 | 2025-08-08 | Common Stock (18066.00) | 18066.00 | Direct |
| Stock Options (Right to buy) | $177.32 | 2025-08-08 | Common Stock (13550.00) | 13550.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (11982.00) | 11982.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (15976.00) | 15976.00 | Direct |
| Stock Options (Right to buy) | $108.49 | 2022-08-07 | Common Stock (7494.00) | 7494.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (18819.00) | 18819.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (14114.00) | 14114.00 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2019.
F10: Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F4: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F7: Fully exercisable
F8: Vest 4,517 shares on each 8/8/2019, 8/9/2020 and 4,516 shares on 8/8/2021, 8/9/2022
F9: Vest 3,994 shares on each 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021